GXO Logistics (GXO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
6 May, 2026Executive summary
Revenue reached $3.3 billion in Q1 2026, up 11% year-over-year, with organic revenue growth of 4.1% and adjusted EBITDA of $200 million, up 23%, and adjusted diluted EPS up 72% to $0.50.
Net income was $5 million, reversing a net loss of $95 million in the prior year quarter.
Record sales pipeline of $2.7 billion, with 40% of wins in strategic growth verticals such as aerospace, defense, technology, and life sciences.
Strategic priorities include sharpening commercial execution, strengthening operational discipline, and leading in AI and automation, with accelerated rollout of AI-powered platforms.
Integration of Wincanton progressing, with $60 million in run-rate cost synergies targeted by year-end 2026 and a $21 million impairment recorded for related contract adjustments.
Financial highlights
Adjusted EBITDA margin improved to 6.1%, up 60 basis points year-over-year; adjusted EBITA margin rose to 3.5% from 2.8%.
Net income was $5 million; adjusted net income attributable to GXO was $58 million, up 70.6% year-over-year.
Operating cash flow was $31 million; free cash flow was an outflow of $31 million, reflecting typical seasonality.
Cash and cash equivalents at quarter-end were $794 million, with total liquidity of $1.6 billion and net debt of $2.3 billion.
$227 million in annualized new business wins signed in Q1 2026.
Outlook and guidance
Full-year 2026 organic revenue growth maintained at 4–5%.
Adjusted EBITDA guidance raised to $935–$975 million; adjusted diluted EPS raised to $2.90–$3.20, up 22% at midpoint.
Free cash flow conversion maintained at 30–40%.
Organic growth expected to accelerate in the back half of 2026 and into 2027, supported by strong pipeline and new business wins.
Management expects sufficient liquidity for at least the next 12 months, supported by cash, operating cash flows, and available credit.
Latest events from GXO Logistics
- Record revenue, board refreshment, and strong ESG focus highlight this year's proxy.GXO
Proxy filing22 Apr 2026 - Record revenue and new business wins drive strong 2026 outlook and margin expansion.GXO
Q4 202511 Apr 2026 - Q2 revenue up 19% to $2.85B, but net income down 41% amid acquisition and litigation costs.GXO
Q2 20242 Feb 2026 - Q3 revenue up 28% to $3.2B, strong pipeline, but net income down on higher costs.GXO
Q3 202416 Jan 2026 - Record 2024 results and strong 2025 outlook with margin expansion and robust pipeline.GXO
Q4 202415 Dec 2025 - 2024 saw record results, board refreshment, and a focus on ESG and pay-for-performance.GXO
Proxy Filing1 Dec 2025 - Q2 2025 revenue up 16%, guidance raised, Wincanton deal approved, CEO transition underway.GXO
Q2 202523 Nov 2025 - Q1 revenue up 21% to $3B, net loss $95M, guidance reaffirmed, and NHS contract boosts outlook.GXO
Q1 202519 Nov 2025 - Record Q3 revenue, 71% net income growth, and robust pipeline drive strong outlook.GXO
Q3 202513 Nov 2025